Changzhou, China

Tianyi Yang

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tianyi Yang. Retrieved from https://idiyas.com/inventor/tianyi-yang-xmoi02s2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tianyi Yang

Introduction

Tianyi Yang is a notable inventor based in Changzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of monoclonal antibodies. His work focuses on creating stable pharmaceutical preparations that can be used in treating serious diseases.

Latest Patents

One of Tianyi Yang's most recent patents is a pharmaceutical preparation stably comprising a CD147 monoclonal antibody. This innovative preparation includes a buffer, a protein protectant, and a surfactant. The formulation is designed to maintain the stability of the CD147 monoclonal antibody over an extended period. Furthermore, it is intended for use in developing drugs for treating CD147-related diseases, especially non-small cell lung cancer.

Career Highlights

Throughout his career, Tianyi Yang has demonstrated a strong commitment to advancing medical science. His research has led to breakthroughs that can potentially improve treatment options for patients suffering from various conditions. His dedication to innovation in pharmaceuticals is evident in his patent work.

Collaborations

Tianyi Yang has collaborated with several professionals in his field, including Qiang Feng and Hao Tang. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Tianyi Yang's contributions to the pharmaceutical industry highlight the importance of innovation in medical treatments. His work on the CD147 monoclonal antibody preparation showcases his commitment to improving patient care through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…